Inhalation and Nasal Drug Delivery

Inhalation and nasal routes provide rapid systemic absorption and targeted delivery to the respiratory tract and central nervous system. Dry powder inhalers, metered-dose inhalers, and nebulizers are widely used for treating asthma, COPD, and pulmonary infections. Nasal sprays are gaining attention for vaccine delivery and brain-targeted therapy due to their ability to bypass the blood-brain barrier. Advances in particle engineering, device technology, and mucoadhesive formulations are enhancing drug deposition, stability, and bioavailability. These non-invasive systems offer fast onset and patient convenience.

    Related Conference of Inhalation and Nasal Drug Delivery

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Inhalation and Nasal Drug Delivery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in